Triple dose of Novo Nordisk drug delivers 19% weight loss in trials
Triple dose of Novo Nordisk drug delivers 19% weight loss in trials Summary Financial Times reporting highlights trial results in which a triple dose of a Novo Nordisk weight‑loss drug produced an average 19% reduction in body weight. The finding suggests materially stronger efficacy at higher dosing and has the potential to influence clinical practice, […]